Liu P - Search Results

1

Pharmacological Effects of Salvianolic Acid B Against Oxidative Damage.

Xiao Z, Liu W, Mu YP, Zhang H, Wang XN, Zhao CQ, Chen JM, Liu P. Xiao Z, et al. Among authors: liu p, liu w. Front Pharmacol. 2020 Nov 11;11:572373. doi: 10.3389/fphar.2020.572373. eCollection 2020. Front Pharmacol. 2020. PMID: 33343348 Free PMC article. Review.

2

The Novel Chinese Medicine JY5 Formula Alleviates Hepatic Fibrosis by Inhibiting the Notch Signaling Pathway.

Fu Y, Xiao Z, Tian X, Liu W, Xu Z, Yang T, Hu Y, Zhou X, Fang J, Gao S, Zhang D, Mu Y, Zhang H, Hu Y, Huang C, Chen J, Liu P. Fu Y, et al. Among authors: liu p, liu w. Front Pharmacol. 2021 Sep 22;12:671152. doi: 10.3389/fphar.2021.671152. eCollection 2021. Front Pharmacol. 2021. PMID: 34630075 Free PMC article.

3

Pharmacological effects of Astragaloside IV: a literature review.

Ren S, Zhang H, Mu Y, Sun M, Liu P. Ren S, et al. Among authors: liu p. J Tradit Chin Med. 2013 Jun;33(3):413-6. doi: 10.1016/s0254-6272(13)60189-2. J Tradit Chin Med. 2013. PMID: 24024343 Free article. Review.

4

The effects of inhibiting the activation of hepatic stellate cells by lignan components from the fruits of Schisandra chinensis and the mechanism of schisanhenol.

He X, Chen J, Mu Y, Zhang H, Chen G, Liu P, Liu W. He X, et al. Among authors: liu p, liu w. J Nat Med. 2020 Jun;74(3):513-524. doi: 10.1007/s11418-020-01394-w. Epub 2020 Mar 19. J Nat Med. 2020. PMID: 32193805

5

Gypenosides Ameliorate Carbon Tetrachloride-Induced Liver Fibrosis by Inhibiting the Differentiation of Hepatic Progenitor Cells into Myofibroblasts.

Chen J, Li X, Hu Y, Liu W, Zhou Q, Zhang H, Mu Y, Liu P. Chen J, et al. Among authors: liu p, liu w. Am J Chin Med. 2017;45(5):1061-1074. doi: 10.1142/S0192415X17500574. Epub 2017 Jun 28. Am J Chin Med. 2017. PMID: 28659031

6

The effect and mechanisms of Fuzheng Huayu formula against chronic liver diseases.

Chen J, Hu Y, Chen L, Liu W, Mu Y, Liu P. Chen J, et al. Among authors: liu p, liu w. Biomed Pharmacother. 2019 Jun;114:108846. doi: 10.1016/j.biopha.2019.108846. Epub 2019 Apr 7. Biomed Pharmacother. 2019. PMID: 30965233 Free article. Review.

7

Comparative Network Pharmacology Analysis of Classical TCM Prescriptions for Chronic Liver Disease.

Chen Z, Wang X, Li Y, Wang Y, Tang K, Wu D, Zhao W, Ma Y, Liu P, Cao Z. Chen Z, et al. Among authors: liu p. Front Pharmacol. 2019 Nov 22;10:1353. doi: 10.3389/fphar.2019.01353. eCollection 2019. Front Pharmacol. 2019. PMID: 31824313 Free PMC article.

8

Research Progress in Chinese Medicine Preparations for Promoting Blood Circulation and Removing Blood Stasis for Cirrhotic Patients with Portal Vein Thrombosis Following Splenectomy.

Zhang DQ, Mu YP, Xu Y, Chen JM, Liu P, Liu W. Zhang DQ, et al. Among authors: liu p, liu w. Chin J Integr Med. 2022 Sep;28(9):855-863. doi: 10.1007/s11655-020-3271-8. Epub 2020 Jul 20. Chin J Integr Med. 2022. PMID: 32691285 Review.

9

Hepatoprotective effect of Xiayuxue decoction ethyl acetate fraction against carbon tetrachloride-induced liver fibrosis in mice via inducing apoptosis and suppressing activation of hepatic stellate cells.

Zhang D, Zhang L, Chen G, Xu Y, Yang H, Xiao Z, Chen J, Mu Y, Zhang H, Liu W, Liu P. Zhang D, et al. Among authors: liu p, liu w. Pharm Biol. 2020 Dec;58(1):1229-1243. doi: 10.1080/13880209.2020.1855212. Pharm Biol. 2020. PMID: 33332219 Free PMC article.

10

Yiguanjian decoction inhibits macrophage M1 polarization and attenuates hepatic fibrosis induced by CCl₄/2-AAF.

Xu Y, Xu W, Liu W, Chen G, Jiang S, Chen J, Jian X, Zhang H, Liu P, Mu Y. Xu Y, et al. Among authors: liu p, liu w. Pharm Biol. 2021 Dec;59(1):1150-1160. doi: 10.1080/13880209.2021.1961820. Pharm Biol. 2021. PMID: 34425061 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

24,411 results

Search Page